19 insiders reported 263 Form 4 transactions for NEUROCRINE BIOSCIENCES INC (NBIX) over the past 18 months (most recent 2026-06-30). Recent activity: Lippoldt Darin (Chief Legal Officer) Sell 200 shares, Lippoldt Darin (Chief Legal Officer) Buy 200 shares, Lippoldt Darin (Chief Legal Officer) Buy 8,110 shares, Lippoldt Darin (Chief Legal Officer) Sell 8,110 shares, Lippoldt Darin (Chief Legal Officer) Buy 1,690 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-30 | Lippoldt Darin | Chief Legal Officer | Sell | 200 | $33,913 |
| 2026-06-30 | Lippoldt Darin | Chief Legal Officer | Buy | 200 | $16,298 |
| 2026-06-30 | Lippoldt Darin | Chief Legal Officer | Buy | 8,110 | $660,884 |
| 2026-06-30 | Lippoldt Darin | Chief Legal Officer | Sell | 8,110 | $1.4M |
| 2026-06-30 | Lippoldt Darin | Chief Legal Officer | Buy | 1,690 | $137,718 |
| 2026-06-30 | Lippoldt Darin | Chief Legal Officer | Sell | 1,690 | $288,676 |
| 2026-06-09 | SHERWIN STEPHEN A | Director | Sell | 5,829 | $970,859 |
| 2026-06-09 | Onyia Jude | Chief Scientific Officer | Sell | 2,441 | $0 |
| 2026-06-09 | SHERWIN STEPHEN A | Director | Buy | 10,000 | $797,900 |
| 2026-06-09 | SHERWIN STEPHEN A | Director | Sell | 7,883 | $1.3M |
| 2026-06-09 | SHERWIN STEPHEN A | Director | Sell | 2,549 | $419,156 |
| 2026-06-09 | SHERWIN STEPHEN A | Director | Sell | 6,896 | $1.1M |
| 2026-06-09 | SHERWIN STEPHEN A | Director | Buy | 15,000 | $804,600 |
| 2026-06-09 | SHERWIN STEPHEN A | Director | Sell | 1,843 | $308,357 |
| 2026-06-08 | Norwalk Leslie V | Director | Sell | 1,250 | $210,072 |
| 2026-06-02 | Onyia Jude | Chief Scientific Officer | Buy | 11,000 | $932,140 |
| 2026-06-02 | Delaet Ingrid | Chief Regulatory Officer | Buy | 2,261 | $178,664 |
| 2026-06-02 | Onyia Jude | Chief Scientific Officer | Sell | 11,000 | $1.8M |
| 2026-06-02 | Delaet Ingrid | Chief Regulatory Officer | Sell | 2,261 | $354,321 |
| 2026-05-29 | Onyia Jude | Chief Scientific Officer | Buy | 11,000 | $932,140 |
| 2026-05-29 | Onyia Jude | Chief Scientific Officer | Sell | 11,000 | $1.7M |
| 2026-05-21 | MORROW GEORGE J | Director | Buy | 3,318 | $0 |
| 2026-05-21 | SHERWIN STEPHEN A | Director | Buy | 3,318 | $0 |
| 2026-05-21 | POPS RICHARD F | Director | Buy | 3,318 | $0 |
| 2026-05-21 | LYONS GARY A | Director | Buy | 1,659 | $0 |
Source: SEC Form 4 filings · as of 2026-06-30